We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Radial Artery Occluder Ensures Patent Hemostasis

By HospiMedica International staff writers
Posted on 24 Dec 2020
A novel device helps prevent radial artery occlusion (RAO) following minimally invasive cardiac or vascular percutaneous procedures.

The Medical Ingenuities (Wheaton, IL, USA) PH Band is a universal radial artery compression device designed to achieve hemostasis after a transradial percutaneous procedure. More...
Consisting of a wrist band with Velcro loop bands, a syringe, and two finger cots, it is used in conjunction with a flat micro Doppler ultrasound probe placed under a harnessing band with a built-in transparent window that allows visualization of the access site. The probe is aligned within the window immediately distal to the percutaneous access site.

The PH Band is designed not only to achieve viable hemostasis, but also allow the physician to confirm patency and antegrade blood flow distal to the access site compression bladder. Use of the Doppler probe also helps guide the physician in applying the appropriate amount of pressure to achieve patent hemostasis and avoid over-compression and subsequent occlusion of the radial artery during wound closure.

“Worldwide, interventional cardiologists have been looking for a quick and simple way to achieve patent hemostasis in an effort to reduce complication rates and standardize patient recovery after accessing the radial artery,” said Chip Corrigan, founder and CEO of Medical Ingenuities. “The PH Band will provide the interventional cardiologist new and vital information to properly complete a more effective radial artery closure. This outcome will, in turn, support their goal to reduce overall complications and healthcare costs, and in turn increase patient satisfaction.”

“The PH Band is uniquely poised to deliver on all fronts with the potential to methodically reduce occlusion rates, reduce bleeding, eliminate variability, and minimize valuable nursing resources,” said Paul Grunenwald, MD, of AMITA Alexian Brothers Medical Center (Elk Grove, Il, USA). “The PH Band system provides real time audible and visual feedback to clinicians, to assist them in achieving patent hemostasis. This feedback will confirm the proper application of pressure to attain hemostasis, while ensuring the patency of the radial artery.”

Related Links:
Medical Ingenuities


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.